Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
about
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationTreatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding.Placental ischemia-induced increases in brain water content and cerebrovascular permeability: role of TNF-αTrimethoprim Use prior to Pregnancy and the Risk of Congenital Malformation: A Register-Based Nationwide Cohort Study.Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databasesPregnancy and autoimmune connective tissue diseasesInflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsiaManagement of fertility and pregnancy in women with inflammatory bowel disease: a practical guide.Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review.Psoriasis during pregnancy: characteristics and important management recommendations.The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.Counselling regarding paternal exposures: Can we do better?Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study.Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel.No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.Pregnancy outcomes in women with juvenile idiopathic arthritis: a population-based study.
P2860
Q26765038-271294A6-91C1-4C28-86B4-A19364111AC9Q35892193-70E2E7F1-B719-458C-8315-794A04EF846DQ36422506-E419C6DF-2F77-48D4-8261-8E537B0C441DQ36651303-A44AD35B-82CF-4E52-BC1F-9C9588F6970BQ36729989-2058A7C2-F08C-4DBB-91CE-1FF74265F200Q37100267-E1D5E171-8C8D-4A98-B0F0-ADFDF0639307Q37483133-CBC78BC4-6680-44BF-9CE9-43048F2DA270Q38128948-FA62D255-37BE-46BF-82D3-697320257B04Q38166663-613BCD72-00C9-43AE-8C47-075045E1C41EQ38420877-5C199928-C6EC-4E64-8363-41ECED3C01A4Q39165767-5F05DA42-5998-47AE-896B-0025F54E3793Q39170104-BC244061-5528-441F-A042-2E12CFB9E187Q39399454-4B18D646-BD68-48C1-8B99-F0E5B2329A3EQ40305897-075F7A86-144F-46F8-BF44-2889E225A9A5Q44477550-97863922-3278-4064-88A1-1E8EDE55D891Q45929435-4C588DE8-7328-4590-B6E0-43635934AD82Q51265046-DDB88877-30BF-40AE-AC94-A2BDE7F55A61
P2860
Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@en
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@nl
type
label
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@en
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@nl
prefLabel
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@en
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@nl
P2093
P2860
P1476
Outcomes after anti-rheumatic ...... t women and expectant fathers.
@en
P2093
P2860
P304
P356
10.3109/03009742.2011.626442
P577
2012-03-09T00:00:00Z